Aspirin for Primary and Secondary Prevention of Mortality, Cardiovascular Disease, and Kidney Failure in the Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary

Rationale and Objective: Chronic kidney disease is a risk enhancing factor for cardiovascular disease (CVD) and mortality, and the role of aspirin use is unclear in this population. We investigated the risk and benefits of aspirin use in primary and secondary prevention of CVD in the Chronic Renal I...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jonathan J. Taliercio, Georges Nakhoul, Ali Mehdi, Wei Yang, Daohang Sha, Jesse D. Schold, Scott Kasner, Matthew Weir, Mohamed Hassanein, Sankar D. Navaneethan, Geetha Krishnan, Radhika Kanthety, Alan S. Go, Rajat Deo, Claudia M. Lora, Bernard G. Jaar, Teresa K. Chen, Jing Chen, Jiang He, Mahboob Rahman, Lawrence J. Appel, MD, MPH, Debbie L. Cohen, MD, Harold I. Feldman, MD, MSCE, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Panduranga S. Rao, MD, Vallabh O. Shah, PhD, MS, Mark L. Unruh, MD, MS
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2022-11-01
Schriftenreihe:	Kidney Medicine
Schlagworte:	Aspirin bleeding cardiovascular disease chronic kidney disease CKD CRIC Study
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S259005952200173X
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!